3 unknown. 3 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Unknown 3 |
| Phase 1 | 2 | Unknown 2 |
Follow Primary Biliary Cirrhosis: new trials by email Literature Review of Primary Biliary Cirrhosis trials Research Report on Primary Biliary Cirrhosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of TQA3526 in the Treatment of Primary Biliary Cirrhosis (PBC) TQA3526, Placebo to match TQA3526 - Primary Biliary Cirrhosis | Phase 2 | Unknown | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 130 | 2020-03-20 | 2020-02-20 |
| Pilot Study of FFP104 Dose Escalation in PBC Subjects FFP104 - Primary Biliary Cirrhosis | Phase 1 / Phase 2 | Unknown | Fast Forward Pharmaceuticals | 24 | 2015-05-01 | 2016-08-24 |
| Umbilical Cord Mesenchymal Stem Cells for Patients With Primary Biliary Cirrhosis conventional plus UC-MSC treatment, Conventional plus placebo treatment - Primary Biliary Cirrhosis | Phase 1 / Phase 2 | Unknown | Beijing 302 Hospital | 100 | 2011-10-01 | 2013-05-31 |
Liver Cirrhosis, Biliary (3) · Inflammation (1)
Bile Duct Diseases (3) · Biliary Tract Diseases (3) · Cholestasis (3) · Cholestasis, Intrahepatic (3) · Digestive System Diseases (3) · Fibrosis (3) · Liver Cirrhosis (3) · Liver Diseases (3) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3)
Beijing 302 Hospital (1) · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (1) · Fast Forward Pharmaceuticals (1)
China (2) · Netherlands (1) · United Kingdom (1)
2014 (1)